Unknown PHASE3 INTERVENTIONAL NCT00406146

Amodiaquine+Artesunate vs. Artemether-Lumefantrine for Uncomplicated Malaria in Ghanaian Children

Sponsor: University of Copenhagen

Interventions amodiaquine+artesunate/artemether-lumefantrine

Updated 5 times since 2017 Last updated: Nov 30, 2006 Started: Oct 31, 2004 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Uncomplicated Malaria and is currently ongoing. University of Copenhagen leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Copenhagen
University of Ghana Medical School

Data source: University of Ghana Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Accra, Ghana